195 related articles for article (PubMed ID: 30241227)
1. Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis.
Rodrigues da Cunha Colombo Bonadio R; Gondim Meira Velame Azevedo R; Harada G; Cabral Severino da Costa S; Costa Miranda V; de Freitas D; Abdo Filho E; Alves de Oliveira Ferreira P; Gabrielli F; Del Pilar Estevez Diz M
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241227
[TBL] [Abstract][Full Text] [Related]
2. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
Randall ME; Filiaci V; McMeekin DS; von Gruenigen V; Huang H; Yashar CM; Mannel RS; Kim JW; Salani R; DiSilvestro PA; Burke JJ; Rutherford T; Spirtos NM; Terada K; Anderson PR; Brewster WR; Small W; Aghajanian CA; Miller DS
J Clin Oncol; 2019 Jul; 37(21):1810-1818. PubMed ID: 30995174
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.
Kim HS; Kim JW; Wu HG; Chung HH; Park NH; Song YS; Kang SB; Lee HP
J Obstet Gynaecol Res; 2010 Jun; 36(3):598-604. PubMed ID: 20598043
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant carboplatin and paclitaxel with "sandwich" method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution.
Chinnadurai A; Breadner D; Baloush Z; Lohmann AE; Black M; D'Souza D; Welch S
J Gynecol Oncol; 2024 Mar; 35(2):e16. PubMed ID: 37921600
[TBL] [Abstract][Full Text] [Related]
6. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS
Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy with external beamradiation therapy for high-grade, node-positive endometrial cancer.
Lee LJ; Bu P; Feltmate C; Viswanathan AN
Int J Gynecol Cancer; 2014 Oct; 24(8):1441-8. PubMed ID: 25207463
[TBL] [Abstract][Full Text] [Related]
8. Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes.
Rochet N; Kahn RS; Niemierko A; Delaney TF; Russell AH
Radiat Oncol; 2013 Oct; 8():236. PubMed ID: 24125168
[TBL] [Abstract][Full Text] [Related]
9. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
Milgrom SA; Kollmeier MA; Abu-Rustum NR; Tew WP; Sonoda Y; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
[TBL] [Abstract][Full Text] [Related]
10. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience.
Lan C; Huang X; Cao X; Huang H; Feng Y; Huang Y; Liu J
Expert Opin Pharmacother; 2013 Apr; 14(5):535-42. PubMed ID: 23480059
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
Young MR; Higgins SA; Ratner E; Yu JB; Mani S; Silasi DA; Azodi M; Rutherford T; Schwartz PE; Damast S
Int J Gynecol Cancer; 2015 Mar; 25(3):431-9. PubMed ID: 25621409
[TBL] [Abstract][Full Text] [Related]
13. Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma.
Fujiwara K; Egawa-Takata T; Ueda Y; Kimura T; Yoshino K; Fujita M; Miyatake T; Ohta Y; Kamiura S; Enomoto T; Kimura T
Arch Gynecol Obstet; 2012 May; 285(5):1447-53. PubMed ID: 22127553
[TBL] [Abstract][Full Text] [Related]
14. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of organic anion transporting polypeptide 1B3 and copper transporter 1 expression in endometrial cancer patients treated with paclitaxel and carboplatin.
Ogane N; Yasuda M; Kameda Y; Yokose T; Kato H; Itoh A; Nishino S; Hashimoto Y; Kamoshida S
Biomed Res; 2013 Jun; 34(3):143-51. PubMed ID: 23782748
[TBL] [Abstract][Full Text] [Related]
16. SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.
Kahramanoglu I; Meydanli MM; Taranenka S; Ayhan A; Salman C; Sanci M; Demirkiran F; Ortac F; Haidopoulos D; Sukhin V; Kaidarova D; Stepanyan A; Farazaneh F; Aliyev S; Ulrikh E; Kurdiani D; Yalcin İ; Mavrichev S; Akilli H; Sarı ME; Pletnev A; Aslan K; Bese T; Kairbayev M; Vlachos D; Gultekin M
Int J Gynecol Cancer; 2019 Oct; 29(8):1271-1279. PubMed ID: 31481453
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer.
Tétreault-Laflamme A; Nguyen-Huynh TV; Carrier JF; Samouëlian V; Sauthier P; Beauchemin MC; Barkati M
Int J Gynecol Cancer; 2016 Feb; 26(2):301-6. PubMed ID: 26745699
[TBL] [Abstract][Full Text] [Related]
18. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
Kiess AP; Damast S; Makker V; Kollmeier MA; Gardner GJ; Aghajanian C; Abu-Rustum NR; Barakat RR; Alektiar KM
Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
Pectasides D; Xiros N; Papaxoinis G; Pectasides E; Sykiotis C; Koumarianou A; Psyrri A; Gaglia A; Kassanos D; Gouveris P; Panayiotidis J; Fountzilas G; Economopoulos T
Gynecol Oncol; 2008 May; 109(2):250-4. PubMed ID: 18299146
[TBL] [Abstract][Full Text] [Related]
20. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
